382 results on '"Delaidelli, A."'
Search Results
2. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation
3. The eEF2 kinase coordinates the DNA damage response to cisplatin by supporting p53 activation
4. Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma
5. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
6. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
7. Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
8. Pediatric Brain Tumours: Lessons from the Immune Microenvironment
9. Recent Advances in the Diagnosis and Treatment of Brain Tumors
10. Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
11. Abstract IA019: Identification of metabolic adaptation mechanisms that confer resistance to glutathione depletion in Ewing sarcoma
12. ANTI-TUMOR ACTIVITY OF ENDOGLIN CAR T CELLS AGAINST ADVANCED SARCOMAS
13. Isolated subarachnoid hemorrhage in mild traumatic brain injury: is a repeat CT scan necessary? A single-institution retrospective study
14. TheEIF4EBP1gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma
15. Abstract B044: Elongation control of mRNA translation drives Group 3 medulloblastoma adaptation to nutrient deprivation
16. Supplementary Figure S14 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
17. Data from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
18. Supplementary Data S3 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
19. Supplementary Table S1 from Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
20. Recent Advances in the Diagnosis and Treatment of Brain Tumors
21. Actions speak louder than ORFs: A non-canonical microprotein promotes medulloblastoma oncogenesis
22. Craniocervical fractures management in case of craniocervical pneumatization: case report and review of the literature
23. Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
24. Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
25. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
26. Factors influencing neurological recovery after surgical treatment of spinal meningiomas in the elderly: a meta analysis of multiple centers experience
27. A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
28. TMET-08. ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA ADAPTATION TO NUTRIENT DEPRIVATION
29. TMET-16. ELUCIDATING MECHANISMS OF ENHANCED OXIDATIVE PHOSPHORYLATION IN MYC-AMPLIFIED MEDULLOBLASTOMA
30. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma
31. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
32. RNA modifications in brain tumorigenesis
33. α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
34. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
35. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
36. Surgical Treatment of Spinal Meningiomas in the Elderly (≥75 Years): Which Factors Affect the Neurological Outcome? An International Multicentric Study of 72 Cases
37. A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma
38. Translational control in brain pathologies: biological significance and therapeutic opportunities
39. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
40. Pediatric Brain Tumours: Lessons from the Immune Microenvironment
41. Abstract 2593: A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
42. Chafe et al Supplementary Materials and Methods from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
43. Abstract 4515: PIONEER: harnessing multi-omics data to enhance immunotherapeutic target discovery and development
44. Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
45. Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
46. Data from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
47. Supplementary Table from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
48. Supplementary Data from Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
49. RNA modifications in brain tumorigenesis
50. Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.